Meanwhile, the young patients (≤65 years old) tend to have a higher RSPO3 expression (Figure 3(h)); the G3 GC patients might have a higher FNDC1 and RSPO3 expression than G1-2 patients (Figure 3(i)); the stage III-IV patients might have an higher RSPO3 expression (Figure 3(j)); the T3-4 GC patients might have a higher FNDC1 and RSPO3 expression than T1-2 patients (Figure 3(k)); the N1-3 GC patients might have a higher RSPO3 expression than N0 patients (Figure 3(l)). The gene discussed is FNDC1; the disease is gastric cancer.